Behrad Derakhshan

CIK: 0001853109

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (42.1%)

Position reduction

Option Exercises (M)6 (31.6%)

Derivative conversions

Awards (A)5 (26.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

EWTX

Edgewise Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
304 shares at avg. $44.50$14K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
5.8K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Exercise(M)
Direct
7.5K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
2.2K shares at avg. $43.79$95K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
150 shares at avg. $44.44$7K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Sale(S)
Direct
2.5K shares at avg. $43.70$108K
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Restricted Stock Units
Direct
50K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Stock Option (Right to Buy)
Direct
180K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Award(A)
Restricted Stock Units
Direct
30K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Exercise(M)
Direct
5.8K shares-
EWTX
Edgewise Therapeutics, Inc.
Aug 12, 2025
Sale(S)
Direct
2.5K shares at avg. $13.39$33K
EWTX
Edgewise Therapeutics, Inc.
May 2, 2025
Sale(S)
Direct
1.7K shares at avg. $16.45$28K
EWTX
Edgewise Therapeutics, Inc.
May 1, 2025
Exercise(M)
Direct
5.2K shares-
EWTX
Edgewise Therapeutics, Inc.
Feb 5, 2025
Exercise(M)
Direct
10K shares at avg. $1.93$19K
EWTX
Edgewise Therapeutics, Inc.
Feb 5, 2025
Sale(S)
Direct
10K shares at avg. $30.03$300K
EWTX
Edgewise Therapeutics, Inc.
Sep 20, 2024
Exercise(M)
Direct
42.1K shares at avg. $1.93$81K
EWTX
Edgewise Therapeutics, Inc.
Sep 20, 2024
Sale(S)
Direct
42.1K shares at avg. $29.03$1.2M

		Type	Shares	Price		Ownership
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	304	$44.50	$13,529	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,781	-	$0	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	7,500	-	$0	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	2,171	$43.79	$95,075	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	150	$44.44	$6,666	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Sale(S)	2,475	$43.70	$108,154	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	50,000	-	-	Direct
Aug 12, 2026	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	180,000	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Award(A) Restricted Stock Units	30,000	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,781	-	-	Direct
Aug 12, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	2,491	$13.39	$33,360	Direct
May 2, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	1,691	$16.45	$27,824	Direct
May 1, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	5,209	-	-	Direct
Feb 5, 2025	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	10,000	$1.93	$19,300	Direct
Feb 5, 2025	EWTX Edgewise Therapeutics, Inc.	Sale(S)	10,000	$30.03	$300,300	Direct
Sep 20, 2024	EWTX Edgewise Therapeutics, Inc.	Exercise(M)	42,068	$1.93	$81,191	Direct
Sep 20, 2024	EWTX Edgewise Therapeutics, Inc.	Sale(S)	42,068	$29.03	$1,221,133	Direct

1-19 of 19 transactions

About Derakhshan Behrad

Derakhshan Behrad (SEC CIK 0001853109) files insider reports with the SEC as Chief Business Officer of Edgewise Therapeutics, Inc. (EWTX).

Signal8 holds 6 ownership filings by Derakhshan Behrad, all Form 4s, filed between Sep 24, 2024 and Aug 17, 2026. Those filings report 19 transactions, from Sep 20, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Derakhshan Behrad's filings is in BOULDER, CO.

Recent filings by Derakhshan Behrad

Aug 12, 2026: Grant or award of EWTX derivative securities (Form 4, code A).
Aug 12, 2026: Open-market sale of EWTX shares (Form 4, code S).
Aug 12, 2026: Option exercises of EWTX shares (2 lines, Form 4, code M).
Aug 12, 2026: Open-market sales of EWTX shares (3 lines, Form 4, code S).
Aug 12, 2026: Grants or awards of EWTX derivative securities (2 lines, Form 4, code A).

Other insiders filing for Edgewise Therapeutics, Inc. (EWTX)

Fox Jonathan C, Director
Nofi Michael, Chief Financial Officer
Donovan Joanne M., CMO
Russell Alan J, Chief Scientific Officer
MOORE JOHN R, General Counsel
KOCH KEVIN, President and CEO

How to read Form 4 transaction codes